)
)
PharmaSGP Holding Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from PharmaSGP Holding SE
Access all reports
PharmaSGP Holding SE is a health technology company that specializes in the development, sale, and marketing of non-prescription (over-the-counter) drugs, chemical-free painkillers, and herbal medicines. Established in 2012 and headquartered in Gräefelfing, Germany, the company offers a broad range of healthcare products targeting various medical conditions without the use of chemical substances. Its portfolio includes well-known brands such as Baldriparan, Formigran, Spalt, Kamol, RubaXX, Restaxil, DESEO, and NERADIN, each designed to address specific health concerns like sleep disorders, pain relief, rheumatic pain, and sexual health, among others. Its shares are listed on the XETRA.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
PSG
Country
🇩🇪 Germany